source
- Medicare launches $50/month coverage for Wegovy and Zepbound but withholds cost to taxpayersMedicare announced a temporary “GLP-1 Bridge” program that will allow adults 65 and older to receive the obesity treatments Wegovy and Zepbound for $50 a month beginning July 1. The program runs t…
- Abivax’s ulcerative colitis pill shows high remission rates but cancer cases spark safety worriesAbivax reported that its experimental oral therapy for ulcerative colitis achieved strong efficacy in a Phase 3 maintenance trial involving 580 patients who had previously responded in shorter stud…